Table 2.
Gender Identity-Related Characteristics
| Variable | TM (n=73), n (%) | TF (n=72), n (%) | Total (N=145), n (%) | TM vs. TF, p |
|---|---|---|---|---|
| Gender identity when established care at community health center | <0.001 | |||
| Female | 5 (6.8) | 49 (68.1) | 54 (37.2) | |
| Male | 49 (67.1) | 7 (9.7) | 56 (38.6) | |
| Genderqueer/nonbinary | 19 (26.0) | 16 (22.2) | 35 (24.1) | |
| Hormones prescribed by primary care provider | 69 (94.5) | 69 (95.8) | 138 (95.2) | 1.000 |
| Current medically unmonitored hormone use | 0 (0.0) | 3 (4.2) | 3 (2.1) | 0.120 |
| Any past medically unmonitored hormone use | 0 (0.0) | 6 (8.3) | 6 (4.1) | 0.013 |
| Any gender-affirming surgery | 27 (37.0) | 20 (27.8) | 47 (32.4) | 0.314 |
| Age of hormone therapy initiation | ||||
| Mean (SD) | 27.9 (7.1) | 33.3 (13.2) | 31.8 (11.1) | |
| Median | 24.0 | 27.0 | 27.0 | 0.001 |
| Range | 8–50 | 15–64 | 8–64 | |
Bold indicates statistical significance (p<0.05). Reported p-values are from Fisher's exact tests wherein cell sizes are small (<5). Response rate was 100% for all variables except where table states “Not indicated.”